IPF biotech Celea gets $180M to follow paths of PureTech's Karuna, Seaport

Robert Lyne, PureTech Health CEO July 2, 2026 10:28 AM EDT Financing IPF biotech Ce­lea gets $180M to fol­low paths of PureTech's Karuna, Sea­port Kyle LaHucik Biotech Correspondent With ma­jor back­ing from new in­vestors, Ce­lea Ther­a­peu­tics hopes to fol­low in the foot­steps of its sib­lings Sea­port Ther­a­peu­tics and Karuna Ther­a­peu­tics. Ce­lea has cor­ralled … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER